Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality

Therapeutic Approaches to the Regulation of Metabolism of High-Density Lipoprotein

(2013) Bo Zhang et al.   CIRCULATION JOURNAL

High-Density Lipoproteins

(2013) Wijtske Annema et al.   CIRCULATION JOURNAL

High-density lipoproteins: A consensus statement from the National Lipid Association

(2013) Peter P. Toth et al.   Journal of Clinical Lipidology

Smoking Promotes Subclinical Atherosclerosis in Apparently Healthy Men

(2012) Shoji Sanada et al.   CIRCULATION JOURNAL

Prebeta-1 HDL and coronary heart disease

(2012) John P. Kane et al.   CURRENT OPINION IN LIPIDOLOGY

Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis

(2012) Suguru Yamamoto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

(2012) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relation of Increased Prebeta-1 High-Density Lipoprotein Levels to Risk of Coronary Heart Disease

(2011) Lin T. Guey et al.   AMERICAN JOURNAL OF CARDIOLOGY

Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus

(2011) Douwe J. Mulder et al.   ATHEROSCLEROSIS

Dysfunctional High-Density Lipoprotein and the Potential of Apolipoprotein A-1 Mimetic Peptides to Normalize the Composition and Function of Lipoproteins

(2011) Satoshi Imaizumi et al.   CIRCULATION JOURNAL

HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

(2011) R. S. Rosenson et al.   CLINICAL CHEMISTRY

Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes

(2011) C. Morgantini et al.   DIABETES

A new look at HDL in coronary disease: can we escape natural history?

(2011) S. Gielen et al.   HEART

Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

(2011) Christian Besler et al.   JOURNAL OF CLINICAL INVESTIGATION

The Anti-Oxidative Capacity of High-Density Lipoprotein Is Reduced in Acute Coronary Syndrome But Not in Stable Coronary Artery Disease

(2011) Parin J. Patel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Controlled Open Comparative Trial of Varenicline vs Nicotine Patch in Adult Smokers

(2010) Hitomi Tsukahara et al.   CIRCULATION JOURNAL

High Pre- 1 HDL Concentrations and Low Lecithin: Cholesterol Acyltransferase Activities Are Strong Positive Risk Markers for Ischemic Heart Disease and Independent of HDL-Cholesterol

(2010) A. A. Sethi et al.   CLINICAL CHEMISTRY

Modifying Apolipoprotein A-I by Malondialdehyde, but Not by an Array of Other Reactive Carbonyls, Blocks Cholesterol Efflux by the ABCA1 Pathway

(2010) Baohai Shao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: The ATTICA Study

(2009) Alexandros D. Tselepis et al.   ATHEROSCLEROSIS

Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma

(2009) Constantinos C. Tellis et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS